Elevated serotonin 1A receptor binding in borderline personality disorder co-morbid with major depressive episodes appears attributable to major depression alone.

Wykaz prac cytowanych wewnątrz artykułu (relacja cites → Publication), pobrany ze zweryfikowanych metadanych PubMed / Crossref:

1. Almeida M, Lee R, Coccaro EF, 2010. Cortisol responses to ipsapirone challenge correlate with aggression, while basal cortisol levels correlate with impulsivity, in personality disorder and healthy volunteer subjects. Journal of Psychiatric Research 44 (14), 874–880.
   pubmed_reference_list
2. American Psychiatric Association, 2013. Diagnostic and statistical manual of mental disorders, 5th edition ed.
   pubmed_reference_list
3. Barratt ES, 1965. Factor Analysis of Some Psychometric Measures of Impulsiveness and Anxiety. Psychological Reports 16, 547–554.
   pubmed_reference_list
4. Beck AT, Kovacs M, Weissman A, 1979. Assessment of suicidal intention: the Scale for Suicide Ideation. Journal of Consulting and Clinical Psychology 47 (2), 343–352.
   pubmed_reference_list
5. Brown GL, Ebert MH, Goyer PF, Jimerson DC, Klein WJ, Bunney WE, Goodwin FK, 1982. Aggression, suicide, and serotonin: relationships to CSF amine metabolites. American Journal of Psychiatry 139 (6), 741–746.
   pubmed_reference_list
6. Brown GL, Goodwin FK, Ballenger JC, Goyer PF, Major LF, 1979. Aggression in humans correlates with cerebrospinal fluid amine metabolites. Psychiatry Research 1 (2), 131–139.
   pubmed_reference_list
7. Cleare AJ, Bond AJ, 2000. Ipsapirone challenge in aggressive men shows an inverse correlation between 5-HT1A receptor function and aggression. Psychopharmacology 148 (4), 344–349.
   pubmed_reference_list
8. Coccaro EF, Gabriel S, Siever LJ, 1990. Buspirone challenge: preliminary evidence for a role for central 5-HT1a receptor function in impulsive aggressive behavior in humans. Psychopharmacology Bulletin 26 (3), 393–405.
   pubmed_reference_list
9. Coccaro EF, Kavoussi RJ, Hauger RL, 1997. Serotonin function and antiaggressive response to fluoxetine: a pilot study. Biological Psychiatry 42 (7), 546–552.
   pubmed_reference_list
10. Cornelius JR, Soloff PH, Perel JM, Ulrich RF, 1990. Fluoxetine trial in borderline personality disorder. Psychopharmacology Bulletin 26 (1), 151–154.
    pubmed_reference_list
11. DeLorenzo C, Kumar JS, Zanderigo F, Mann JJ, Parsey RV, 2009. Modeling considerations for in vivo quantification of the dopamine transporter using [(11)C]PE2I and positron emission tomography. Journal of Cerebral Blood Flow and Metabolism 29 (7), 1332–1345.
    pubmed_reference_list
12. Diaz SL, Doly S, Narboux-Neme N, Fernandez S, Mazot P, Banas SM, Boutourlinsky K, Moutkine I, Belmer A, Roumier A, Maroteaux L, 2012. 5-HT(2B) receptors are required for serotonin-selective antidepressant actions. Molecular Psychiatry 17 (2), 154–163.
    pubmed_reference_list
13. Drevets WC, Frank E, Price JC, Kupfer DJ, Holt D, Greer PJ, Huang Y, Gautier C, Mathis C, 1999. PET imaging of serotonin 1A receptor binding in depression. Biological Psychiatry 46 (10), 1375–1387.
    pubmed_reference_list
14. Drevets WC, Thase ME, Moses-Kolko EL, Price J, Frank E, Kupfer DJ, Mathis C, 2007. Serotonin-1A receptor imaging in recurrent depression: replication and literature review. Nuclear Medicine and Biology 34 (7), 865–877.
    pubmed_reference_list
15. First M, Spitzer R, Gibbon M, Williams JBW, 1996. Structured Clinical Interview for DSM-IV Axis I Disorders - Patient Edition (SCID-I/P, Version 2.0). Biometrics Research Department, New York State Psychiatric Institute, New York.
    pubmed_reference_list
16. Forster EA, Cliffe IA, Bill DJ, Dover GM, Jones D, Reilly Y, Fletcher A, 1995. A pharmacological profile of the selective silent 5-HT1A receptor antagonist, WAY-100635. European Journal of Pharmacology 281 (1), 81–88.
    pubmed_reference_list
17. Garcia-Garcia AL, Newman-Tancredi A, Leonardo ED, 2014. 5-HT(1A) [corrected] receptors in mood and anxiety: recent insights into autoreceptor versus heteroreceptor function. Psychopharmacology 231 (4), 623–636.
    pubmed_reference_list
18. Gray NA, Milak MS, DeLorenzo C, Ogden RT, Huang YY, Mann JJ, Parsey RV, 2013. Antidepressant treatment reduces serotonin-1A autoreceptor binding in major depressive disorder. Biological Psychiatry 74 (1), 26–31.
    pubmed_reference_list
19. Hamilton M, 1960. A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry 23, 56–62.
    pubmed_reference_list
20. Hansenne M, Pitchot W, Ansseau M, 2002. Serotonin, personality and borderline personality disorder. Acta Neuropsychiatr 14 (2), 66–70.
    pubmed_reference_list
21. Hwang DR, Simpson NR, Montoya J, Man JJ, Laruelle M, 1999. An improved one-pot procedure for the preparation of [11C-carbonyl]-WAY100635. Nuclear Medicine and Biology 26 (7), 815–819.
    pubmed_reference_list
22. Kavoussi RJ, Liu J, Coccaro EF, 1994. An open trial of sertraline in personality disordered patients with impulsive aggression. Journal of Clinical Psychiatry 55 (4), 137–141.
    pubmed_reference_list
23. Markovitz PJ, Calabrese JR, Schulz SC, Meltzer HY, 1991. Fluoxetine in the treatment of borderline and schizotypal personality disorders. American Journal of Psychiatry 148 (8), 1064–1067.
    pubmed_reference_list
24. Matheson GJ, Zanderigo F, Miller JM, Bartlett EA, Mann JJ, Ogden RT, 2024. PET imaging of the serotonin 1A receptor in major depressive disorder: Hierarchical multivariate analysis of [(11) C]WAY100635 overcomes outcome measure discrepancies. Imaging Neurosci (Camb) 2.
    pubmed_reference_list
25. Meltzer CC, Price JC, Mathis CA, Butters MA, Ziolko SK, Moses-Kolko E, Mazumdar S, Mulsant BH, Houck PR, Lopresti BJ, Weissfeld LA, Reynolds CF, 2004. Serotonin 1A receptor binding and treatment response in late-life depression. Neuropsychopharmacology 29 (12), 2258–2265.
    pubmed_reference_list
26. Mendoza DL, Bravo HA, Swanson HH, 1999. Antiaggresive and anxiolytic effects of gepirone in mice, and their attenuation by WAY 100635. Pharmacology, Biochemistry and Behavior 62 (3), 499–509.
    pubmed_reference_list
27. Meyer JH, Wilson AA, Rusjan P, Clark M, Houle S, Woodside S, Arrowood J, Martin K, Colleton M, 2008. Serotonin2A receptor binding potential in people with aggressive and violent behaviour. Journal of Psychiatry and Neuroscience 33 (6), 499–508.
    pubmed_reference_list
28. Miczek KA, Faccidomo S, De Almeida RM, Bannai M, Fish EW, Debold JF, 2004. Escalated aggressive behavior: new pharmacotherapeutic approaches and opportunities. Annals of the New York Academy of Sciences 1036, 336–355.
    pubmed_reference_list
29. Milak MS, DeLorenzo C, Zanderigo F, Prabhakaran J, Kumar JS, Majo VJ, Mann JJ, Parsey RV, 2010. In vivo quantification of human serotonin 1A receptor using 11C-C-UMI-101, an agonist PET radiotracer. Journal of Nuclear Medicine 51 (12), 1892–1900.
    pubmed_reference_list
30. Milak MS, Pantazatos S, Rashid R, Zanderigo F, DeLorenzo C, Hesselgrave N, Ogden RT, Oquendo MA, Mulhern ST, Miller JM, Burke AK, Parsey RV, Mann JJ, 2018. Higher 5-HT1A autoreceptor binding as an endophenotype for major depressive disorder identified in high risk offspring - A pilot study. Psychiatry Res Neuroimaging 276, 15–23.
    pubmed_reference_list
31. Miller JM, Brennan KG, Ogden TR, Oquendo MA, Sullivan GM, Mann JJ, Parsey RV, 2009. Elevated serotonin 1A binding in remitted major depressive disorder: evidence for a trait biological abnormality. Neuropsychopharmacology 34 (10), 2275–2284.
    pubmed_reference_list
32. New AS, Buchsbaum MS, Hazlett EA, Goodman M, Koenigsberg HW, Lo J, Iskander L, Newmark R, Brand J, O'Flynn K, Siever LJ, 2004. Fluoxetine increases relative metabolic rate in prefrontal cortex in impulsive aggression. Psychopharmacology 176 (3–4), 451–458.
    pubmed_reference_list
33. New AS, Hazlett EA, Buchsbaum MS, Goodman M, Reynolds D, Mitropoulou V, Sprung L, Shaw RB Jr., Koenigsberg H, Platholi J, Silverman J, Siever LJ, 2002. Blunted prefrontal cortical 18fluorodeoxyglucose positron emission tomography response to meta-chlorophenylpiperazine in impulsive aggression. Archives of General Psychiatry 59 (7), 621–629.
    pubmed_reference_list
34. Norden MJ, 1989. Fluoxetine in borderline personality disorder. Progress in Neuro-Psychopharmacology and Biological Psychiatry 13 (6), 885–893.
    pubmed_reference_list
35. Oquendo MA, Galfalvy H, Sullivan GM, Miller JM, Milak MM, Sublette ME, Cisneros-Trujillo S, Burke AK, Parsey RV, Mann JJ, 2016. Positron Emission Tomographic Imaging of the Serotonergic System and Prediction of Risk and Lethality of Future Suicidal Behavior. JAMA Psychiatry 73 (10), 1048–1055.
    pubmed_reference_list
36. Oquendo M, Krunic A, Parsey R, Milak M, Malone K, Anderson A, Van Heertum R, John Mann J, 2005. Positron Emission Tomography of Regional Brain Metabolic Responses to a Serotonergic Challenge in Major Depressive Disorder with and without Borderline Personality Disorder. Neuropsychopharmacology 30 (6), 1163–1172.
    pubmed_reference_list
37. Oquendo MA, Halberstam B, Mann JJ, 2003. Risk factors for suicidal behavior: utility and limitations of research instruments, in: First MB (Ed.), Standardized Evaluation in Clinical Practice. APPI Press, Washington, D.C., pp. 103–130.
    pubmed_reference_list
38. Oquendo MA, Russo SA, Underwood MD, Kassir SA, Ellis SP, Mann JJ, Arango V, 2006. Higher postmortem prefrontal 5-HT2A receptor binding correlates with lifetime aggression in suicide. Biological Psychiatry 59 (3), 235–243.
    pubmed_reference_list
39. Parsey RV, Ogden RT, Miller JM, Tin A, Hesselgrave N, Goldstein E, Mikhno A, Milak M, Zanderigo F, Sullivan GM, Oquendo MA, Mann JJ, 2010. Higher serotonin 1A binding in a second major depression cohort: modeling and reference region considerations. Biological Psychiatry 68 (2), 170–178.
    pubmed_reference_list
40. Parsey RV, Olvet DM, Oquendo MA, Huang YY, Ogden RT, Mann JJ, 2006b. Higher 5-HT1A receptor binding potential during a major depressive episode predicts poor treatment response: preliminary data from a naturalistic study. Neuropsychopharmacology 31 (8), 1745–1749.
    pubmed_reference_list
41. Parsey R, Oquendo M, Ogden R, Olvet D, Simpson N, Huang Y, Vanheertum R, Arango V, Mann J, 2006a. Altered Serotonin 1A Binding in Major Depression: A [carbonyl-C-11]WAY100635 Positron Emission Tomography Study. Biological Psychiatry 59 (2), 106–113.
    pubmed_reference_list
42. Parsey RV, Oquendo MA, Ogden RT, Olvet DM, Simpson N, Huang YY, Van Heertum RL, Arango V, Mann JJ, 2006c. Altered serotonin 1A binding in major depression: a [carbonyl-C-11]WAY100635 positron emission tomography study. Biological Psychiatry 59 (2), 106–113.
    pubmed_reference_list
43. Parsey RV, Oquendo MA, Simpson NR, Ogden RT, Van Heertum R, Arango V, Mann JJ, 2002. Effects of sex, age, and aggressive traits in man on brain serotonin 5-HT1A receptor binding potential measured by PET using [C-11]WAY-100635. Brain Research 954 (2), 173–182.
    pubmed_reference_list
44. Parsey RV, Slifstein M, Hwang DR, Abi-Dargham A, Simpson N, Mawlawi O, Guo NN, Van Heertum R, Mann JJ, Laruelle M, 2000. Validation and reproducibility of measurement of 5-HT1A receptor parameters with [carbonyl-11C]WAY-100635 in humans: comparison of arterial and reference tisssue input functions. Journal of Cerebral Blood Flow and Metabolism 20 (7), 1111–1133.
    pubmed_reference_list
45. Peng L, Gu L, Li B, Hertz L, 2014. Fluoxetine and all other SSRIs are 5-HT2B Agonists - Importance for their Therapeutic Effects. Curr Neuropharmacol 12 (4), 365–379.
    pubmed_reference_list
46. Rinne T, van den Brink W, Wouters L, van Dyck R, 2002. SSRI treatment of borderline personality disorder: a randomized, placebo-controlled clinical trial for female patients with borderline personality disorder. American Journal of Psychiatry 159 (12), 20482054.
    pubmed_reference_list
47. Rosell DR, Thompson JL, Slifstein M, Xu X, Frankle WG, New AS, Goodman M, Weinstein SR, Laruelle M, Abi-Dargham A, Siever LJ, 2010. Increased serotonin 2A receptor availability in the orbitofrontal cortex of physically aggressive personality disordered patients. Biological Psychiatry 67 (12), 1154–1162.
    pubmed_reference_list
48. Salzman C, Wolfson AN, Schatzberg A, Looper J, Henke R, Albanese M, Schwartz J, Miyawaki E, 1995. Effect of fluoxetine on anger in symptomatic volunteers with borderline personality disorder. Journal of Clinical Psychopharmacology 15 (1), 23–29.
    pubmed_reference_list
49. Sargent PA, Kjaer KH, Bench CJ, Rabiner EA, Messa C, Meyer J, Gunn RN, Grasby PM, Cowen PJ, 2000. Brain serotonin1A receptor binding measured by positron emission tomography with [11C]WAY-100635: effects of depression and antidepressant treatment. Archives of General Psychiatry 57 (2), 174–180.
    pubmed_reference_list
50. Shah R, Zanarini MC, 2018. Comorbidity of Borderline Personality Disorder: Current Status and Future Directions. Psychiatric Clinics of North America 41 (4), 583–593.
    pubmed_reference_list
51. Siever LJ, Buchsbaum MS, New AS, Spiegel-Cohen J, Wei T, Hazlett EA, Sevin E, Nunn M, Mitropoulou V, 1999. d,l-fenfluramine response in impulsive personality disorder assessed with [18F]fluorodeoxyglucose positron emission tomography. Neuropsychopharmacology 20 (5), 413–423.
    pubmed_reference_list
52. Simpson EB, Yen S, Costello E, Rosen K, Begin A, Pistorello J, Pearlstein T, 2004. Combined dialectical behavior therapy and fluoxetine in the treatment of borderline personality disorder. Journal of Clinical Psychiatry 65 (3), 379–385.
    pubmed_reference_list
53. Soloff PH, Chiappetta L, Mason NS, Becker C, Price JC, 2014. Effects of serotonin-2A receptor binding and gender on personality traits and suicidal behavior in borderline personality disorder. Psychiatry Research 222 (3), 140–148.
    pubmed_reference_list
54. Soloff PH, Meltzer CC, Greer PJ, Constantine D, Kelly TM, 2000. A fenfluramine-activated FDG-PET study of borderline personality disorder. Biological Psychiatry 47 (6), 540–547.
    pubmed_reference_list
55. Sullivan GM, Ogden RT, Huang YY, Oquendo MA, Mann JJ, Parsey RV, 2013. Higher in vivo serotonin-1a binding in posttraumatic stress disorder: a PET study with [11C]WAY-100635. Depression and Anxiety 30 (3), 197–206.
    pubmed_reference_list
56. Sullivan GM, Ogden RT, Oquendo MA, Kumar JS, Simpson N, Huang YY, Mann JJ, Parsey RV, 2009a. Positron Emission Tomography Quantification of Serotonin-1A Receptor Binding in Medication-Free Bipolar Depression. Biological Psychiatry.
    pubmed_reference_list
57. Sullivan GM, Ogden RT, Oquendo MA, Kumar JS, Simpson N, Huang YY, Mann JJ, Parsey RV, 2009b. Positron emission tomography quantification of serotonin-1A receptor binding in medication-free bipolar depression. Biological Psychiatry 66 (3), 223–230.
    pubmed_reference_list
58. Sullivan GM, Oquendo MA, Milak M, Miller JM, Burke A, Ogden RT, Parsey RV, Mann JJ, 2015. Positron emission tomography quantification of serotonin(1A) receptor binding in suicide attempters with major depressive disorder. JAMA Psychiatry 72 (2), 169–178.
    pubmed_reference_list
59. Takahashi A, Quadros IM, de Almeida RM, Miczek KA, 2012. Behavioral and pharmacogenetics of aggressive behavior. Curr Top Behav Neurosci 12, 73–138.
    pubmed_reference_list
60. Wang L, Zhou C, Zhu D, Wang X, Fang L, Zhong J, Mao Q, Sun L, Gong X, Xia J, Lian B, Xie P, 2016. Serotonin-1A receptor alterations in depression: a meta-analysis of molecular imaging studies. BMC psychiatry 16 (1), 319.
    pubmed_reference_list
61. Witte AV, Floel A, Stein P, Savli M, Mien LK, Wadsak W, Spindelegger C, Moser U, Fink M, Hahn A, MItterhauser M, Kletter K, Kasper S, Lanzenberger R, 2009. Aggression is related to frontal serotonin-1A receptor distribution as revealed by PET in healthy subjects. Human Brain Mapping 30, 2558–2570.
    pubmed_reference_list

Dokładne dopasowania identyfikatorów

Nie znaleziono dopasowań w tej grupie.

Kandydaci do ręcznej kontroli

• Differentiating Suicide Attempt History Among Individuals with Borderline Personality Disorder Engaging in Non-Suicidal Self-Injury. · src_42008398 · PROBABLE_MATCH · rok 2026

Konflikty

Nie znaleziono dopasowań w tej grupie.

Podobieństwo nie scala rekordów i nie potwierdza tożsamości publikacji.

Zakres: jawne relacje claims[].source_ids[] powiązane z publikacją.